(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DURALACTIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DURALACTIN

ST13

US500000078126585

Class

5

Filing

78126585

Registration

2760369

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

05/09/2023

Trademark type

Word

Nice classes

5

Filing date

05/06/2002

Registration date

09/02/2003

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/09/2023

Last transaction

05/09/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/08/2003

First use in commerce

01/08/2003

Drawing code

1

Owner type

03

Owner location

Shawnee, KS, US

Examiner

MEIER, SHARON A

Law office

M70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

PEGASUS LABORATORIES, INC.
Farnam Companies, Inc.

Representatives

Joshua W. Newman Reed Smith LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Nutritional supplements for the management of bone and/or joint disordersosteo-arthritis and inflammation in companion animals

Publications

History of USPTO decisions and trademark events.

41 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/09/2023

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

05/09/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/09/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/09/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

10/25/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/25/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/25/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/25/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/25/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/25/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/02/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/07/2016

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/06/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/06/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/06/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/06/2013

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/10/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

05/10/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/16/2009

PLGL

ASSIGNED TO PARALEGAL

06/10/2009

E815

TEAS SECTION 8 & 15 RECEIVED

06/05/2009

A7OK

AMENDMENT UNDER SECTION 7 - PROCESSED

11/20/2008

FAXX

FAX RECEIVED

10/02/2008

PRAM

POST REGISTRATION ACTION MAILED - SEC. 7

06/21/2008

PLGL

ASSIGNED TO PARALEGAL

06/09/2008

ES7R

TEAS SECTION 7 REQUEST RECEIVED

05/07/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

09/02/2003

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/27/2003

DOCK

ASSIGNED TO EXAMINER

06/24/2003

CFIT

CASE FILE IN TICRS

06/20/2003

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/10/2003

IUAF

USE AMENDMENT FILED

06/03/2003

EISU

TEAS STATEMENT OF USE RECEIVED

06/03/2003

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/27/2003

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

02/11/2003

MAIL

PAPER RECEIVED

11/21/2002

PUBO

PUBLISHED FOR OPPOSITION

11/19/2002

NPUB

NOTICE OF PUBLICATION

10/30/2002

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/18/2002

GNEA

EXAMINERS AMENDMENT E-MAILED

09/18/2002

DOCK

ASSIGNED TO EXAMINER

09/11/2002

Continuous trademark protection

Get notified about every new filing that threatens DURALACTIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.